DuPont De Nemours Earnings, Revenue Beat in Q1 By

© Reuters. DuPont De Nemours Earnings, Revenue Beat in Q1 – DuPont (NYSE:) De Nemours reported on Tuesday first quarter that beat analysts’ forecasts and revenue that topped expectations.

DuPont De Nemours announced earnings per share of $0.91 on revenue of $3.98B. Analysts polled by anticipated EPS of $0.7497 on revenue of $3.85B.

DuPont De Nemours shares are up 10% from the beginning of the year, still down 10.30% from its 52 week high of $87.27 set on January 12. They are outperforming the S&P Global 100 which is up 9.42% from the start of the year.

DuPont De Nemours follows other major Healthcare sector earnings this month

DuPont De Nemours’s report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.

Abbott Labs had beat expectations on April 20 with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.

Stay up-to-date on all of the upcoming earnings reports by visiting’s earnings calendar

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button